Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
1. Rallybio sells REV102 interest to Recursion for up to $25 million. 2. Deal includes $7.5 million upfront payment, extending cash runway into mid-2027. 3. Rallybio eligible for milestone payments and low single-digit royalties on future sales. 4. Recursion announces workforce reduction to manage cash burn effectively. 5. RLYB stock increased 36.8% following the announcement.